| Ident. | Authors (with country if any) | Title |
|---|
| 000048 (2020) |
Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni] | 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. |
| 000054 (2019) |
Maxime Samson [France] ; Hélène Greigert [France] ; Thibault Ghesquière [France] ; Bernard Bonnotte [France] | [Treatment of giant cell arteritis]. |
| 000064 (2019) |
Sara Monti [Italie] ; Ana F. Águeda [Portugal] ; Raashid Ahmed Luqmani [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Maria Cid [Espagne] ; Christian Dejaco [Italie, Autriche] ; Alfred Mahr [France] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Wolfgang Schmidt [Allemagne] ; Bernhard Hellmich [Allemagne] | Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis |
| 000069 (2019) |
Simon Galmiche [France] ; David Buob [France] ; Soraya Fellahi [France] ; Jean-Philippe Bastard [France] ; Gilles Grateau [France] ; Sophie Georgin-Lavialle [France] | Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis. |
| 000094 (2019) |
Abrar-Ahmad Zulfiqar [France] ; Rizwan Niazi [France] ; Jean-Loup Pennaforte [France] ; Emmanuel Andres [France] | Late-onset rheumatoid arthritis: clinical, biological, and therapeutic features About a retrospective study. |
| 000110 (2019) |
Noemi Muszbek [Royaume-Uni] ; Clare Proudfoot [Royaume-Uni] ; Marie Fournier [France] ; Chieh-I Chen [États-Unis] ; Andreas Kuznik [États-Unis] ; Zsofia Kiss [Royaume-Uni] ; Peter Gal [Hongrie] ; Kaleb Michaud [États-Unis] | Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs |
| 000147 (2018) |
Alvise Berti [États-Unis] ; Divi Cornec [France] ; Jose R. Medina Inojosa [États-Unis] ; Eric L. Matteson [États-Unis] ; M Hassan Murad [États-Unis] | Treatments for giant cell arteritis: Meta-analysis and assessment of estimates reliability using the fragility index. |
| 000231 (2017) |
Bénédicte Watelet [France] ; Maxime Samson ; Hubert De Boysson [France] ; Boris Bienvenu [France] | Treatment of giant-cell arteritis, a literature review. |
| 000262 (2017) |
Nathalie Balandraud [France] ; Gaetan Texier [France] ; Emmanuel Massy [France] ; Olivier Muis-Pistor [France] ; Marielle Martin [France] ; Isabelle Auger [France] ; Marie-Caroline Guzian [France] ; Sandrine Guis [France] ; Thao Pham [France] ; Jean Roudier [France] | Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study |
| 000269 (2017) |
Kahina Amrouche [France] ; Christophe Jamin [France] | Influence of drug molecules on regulatory B cells. |
| 000272 (2017) |
Johanna Sigaux [France] ; Moustafa Hamze [France] ; Claire Daien [France] ; Jacques Morel [France] ; Roman Krzysiek [France] ; Marc Pallardy [France] ; Bernard Maillere [France] ; Xavier Mariette [France] ; Corinne Miceli-Richard [France] | Immunogenicity of tocilizumab in patients with rheumatoid arthritis. |
| 000279 (2017) |
Josef S. Smolen [Autriche] ; Robert Landewé [Pays-Bas] ; Johannes Bijlsma [Pays-Bas] ; Gerd Burmester [Allemagne] ; Katerina Chatzidionysiou [Suède] ; Maxime Dougados [France] ; Jackie Nam [Royaume-Uni] ; Sofia Ramiro [Pays-Bas] ; Marieke Voshaar [Pays-Bas] ; Ronald Van Vollenhoven [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; Maarten Boers [Pays-Bas] ; Chris D. Buckley [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Vivian Bykerk [États-Unis] ; Mario Cardiel [Mexique] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Pays-Bas] ; Axel Finckh [Suisse] ; Cem Gabay [Suisse] ; Juan Gomez-Reino [Espagne] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Johanna M W. Hazes [Pays-Bas] ; Tom Huizinga [Pays-Bas] ; Meghna Jani [Royaume-Uni] ; Dmitry Karateev [Russie] ; Marios Kouloumas [Suisse] ; Tore Kvien [Norvège] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Iain Mcinnes [Royaume-Uni] ; Eduardo Mysler [Argentine] ; Peter Nash [Australie] ; Karel Pavelka [République tchèque] ; Gyula Po R [Hongrie] ; Christophe Richez [France] ; Piet Van Riel [Pays-Bas] ; Andrea Rubbert-Roth [Allemagne] ; Kenneth Saag [États-Unis] ; Jose Da Silva [Portugal] ; Tanja Stamm [Autriche] ; Tsutomu Takeuchi [Japon] ; René Westhovens [Belgique] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. |
| 000379 (2015) |
Karine Briot [France] ; Stéphanie Rouanet [France] ; Thierry Schaeverbeke [France] ; Fabien Etchepare [France] ; Philippe Gaudin [France] ; Aleth Perdriger [France] ; Muriel Vray [France] ; Ghislaine Steinberg [France] ; Christian Roux [France] | The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. |
| 000445 (2014) |
Claire I. Daïen [France] ; Jacques Morel [France] | Predictive Factors of Response to Biological Disease Modifying Antirheumatic Drugs: Towards Personalized Medicine |
| 000454 (2014) |
Hermine I. Brunner [États-Unis] ; Nicolino Ruperto [Italie] ; Zbigniew Zuber [Pologne] ; Caroline Keane [Royaume-Uni] ; Olivier Harari [Royaume-Uni] ; Andrew Kenwright [Royaume-Uni] ; Peng Lu [États-Unis] ; Ruben Cuttica [Argentine] ; Vladimir Keltsev [Russie] ; Ricardo M. Xavier [Brésil] ; Inmaculada Calvo [Espagne] ; Irina Nikishina [Russie] ; Nadina Rubio-Pérez [Mexique] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Gerd Horneff [Allemagne] ; Violetta Opoka-Winiarska [Pologne] ; Pierre Quartier [France] ; Clovis A. Silva [Brésil] ; Earl Silverman [Canada] ; Alberto Spindler [Argentine] ; Eileen Baildam [Royaume-Uni] ; M Luz Gámir [Espagne] ; Alan Martin [États-Unis] ; Christoph Rietschel [Allemagne] ; Daniel Siri [Argentine] ; Elzbieta Smolewska [Pologne] ; Daniel Lovell [États-Unis] ; Alberto Martini [Italie] ; Fabrizio De Benedetti [Italie] | Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial |
| 000455 (2014) |
Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark] | Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study. |
| 000461 (2014) |
Maxime Dougados [France] ; Karsten Kissel [Australie] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin Mola [Espagne] ; Georg Schett [Allemagne] ; Roberto Gerli [Italie] ; Michael Sejer Hansen [Danemark] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Corrado Bernasconi [Suisse] ; T W J. Huizinga [Pays-Bas] | Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study |
| 000462 (2014) |
T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France] | Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study |
| 000495 (2013) |
Audrey Pierreisnard [France] ; Nahema Issa ; Thomas Barnetche ; Christophe Richez ; Thierry Schaeverbeke | Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexate. |
| 000520 (2013) |
Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas] | Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) |
| 000667 (2011) |
Patricia Guyot [Pays-Bas] ; Peter Taylor [Royaume-Uni] ; Robin Christensen [Danemark] ; Louisa Pericleous [Royaume-Uni] ; Coralie Poncet [France] ; Maximilian Lebmeier [Royaume-Uni] ; Pieter Drost [Belgique] ; Gert Bergman [Pays-Bas] | Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis |
